Knowledge Center
Patent / Jan 01, 2013
Application of high dose compounds via inhalation for treatment of pulmonary diseases
Source:
WO 2013104892
The invention relates to the delivery of high doses of active pharmaceutical compds. via inhalation for the treatment of pulmonary diseases. A pharmaceutical formulation in the form of a powder suitable for inhalation comprises one or more active pharmaceutical ingredients, such as an antibiotic, a mucolytic agent and/or a buffer, wherein the formulation is free of carrier. A powder formulation comprising doxycycline monohydrate combined with sodium citrate filled into TwinCap devices was exemplified.
Also in the Knowledge Center
/ Apr 28, 2023
Capsule filling for DPIs: Linking Process scales through advanced characterisation and Quality by Design
Read more
Scientific Article
/ Mar 09, 2022
Monofluoromethylation of complex pharmaceutical steroids using non-depleting reagents
Read more
Scientific Article
/ Jun 20, 2022
Multivalent NHS-activated acrylates for orthogonal site-selective functionalisation of peptides at cysteine residues
Read more
Scientific Article